Citi analyst Patrick Donnelly lowered the firm’s price target on Icon (ICLR) to $215 from $290 and keeps a Buy rating on the shares as part of ...

Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN. Lekha Gupta Clinical Research Firm ICON Faces ...